CytoMed Therapeutics
GDTC
#8292
Rank
$22.84 M
Marketcap
$1.98
Share price
-2.46%
Change (1 day)
-54.38%
Change (1 year)

Revenue for CytoMed Therapeutics (GDTC)

Revenue in 2022: N/A

In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CytoMed Therapeutics from 2020 to 2022

Annual revenue

Year Revenue Change
2022N/A
2021N/A
2020N/A